Not Yet RecruitingPhase 2

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

123 participantsStarted 2026-04

Plain-language summary

This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Who can participate

Age range18 Years – 58 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female 18 to 58 years of age, inclusive.
✓. Scheduled to undergo PRK surgery and considered to be a good candidate per the Investigator's discretion.
✓. Provide written informed consent (signed and dated informed consent form \[ICF\]) using the Institutional Review Board (IRB)-approved ICF prior to any study-related procedures.
✓. Able to read, understand, and voluntarily sign the ICF and, if applicable, provide written authorization per local privacy regulations.

Exclusion criteria

✕. Women of childbearing potential or non-vasectomized males with partners of childbearing potential are not eligible unless they are using an effective method of contraception and agree to use an effective method of contraception until at least 30 days after study treatment.
✕. Participation in a clinical trial within 30 days prior to Screening.

What they're measuring

Ocular pain intensity following PRK surgery

Timeframe: Assessed at a 24-hour period following PRK surgery

Trial details

NCT IDNCT07412496

SponsorBausch & Lomb Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-02

Contact for this trial

Celia Busby

9453277624 celia.busby@bausch.com

View on ClinicalTrials.gov More Pain, Postoperative trials